Mesoridazine Besylate

• CAT Number: R060388
• CAS Number: 32672-69-8
• Molecular Formula: C27H32N2O4S3
• Molecular Weight: 544.74
• Purity: ≥95%
• Synonyms: 10-[2-(1-Methyl-2-piperidinyl)ethyl]-2-(methylsulfinyl)-10H-phenothiazine Monobenzenesulfonate; Benzenesulfonic Acid, compd. with 10-[2-(1-Methyl-2-piperidinyl)ethyl]-2-(methylsulfinyl)-10H-phenothiazine; Benzenesulfonic Acid, compd. with 10-[2-(1-Me
• Target: Potassium Channel
• Storage: Store at RT
• IUPAC Name: benzenesulfonic acid;10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfinylphenothiazine
• InChI: InChI=1S/C21H26N2OS2.C6H6O3S/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(26(2)24)15-19(21)23;7-10(8,9)6-4-2-1-3-5-6/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3;1-5H,(H,7,8,9)
• InChIKey: CRJHBCPQHRVYBS-UHFFFAOYSA-N
• SMILES: CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)C.C1=CC=C(C=C1)S(=O)(=O)O

Mesoridazine Besylate(CAT: R060388) is an antipsychotic medication belonging to the phenothiazine class, primarily used for the treatment of schizophrenia. It acts by blocking dopamine receptors in the brain, helping to manage symptoms such as hallucinations, delusions, and agitation. Mesoridazine is a metabolite of thioridazine and is considered a second-line treatment due to its potential side effects, including cardiovascular risks like QT prolongation. Despite its reduced use in modern therapy, it remains an important compound for understanding the pharmacology of antipsychotic drugs and their effects on the central nervous system.